Quantum Biopharma (QNTM) Current Assets (2018 - 2026)

Quantum Biopharma has disclosed Current Assets across 9 years of filings, most recently posting $10.4 million for Q1 2026.

• Current Assets for Q1 2026 came in at $10.4 million, up 4.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.4 million (up 4.4% YoY), and the FY2025 annual result was $6.5 million, down 46.25% from the prior year.
• Current Assets came in at $10.4 million for Q1 2026 at Quantum Biopharma, up from $6.5 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $17.9 million in Q4 2022 to a low of $6.5 million in Q4 2025.
• The 5-year median for Current Assets is $10.4 million (2025), against an average of $11.1 million.
• Across the five-year window, Current Assets tumbled 61.14% in 2022 and increased 8.73% in 2024, its largest moves.
• Quantum Biopharma's Current Assets stood at $17.9 million in 2022, then plunged by 37.9% to $11.1 million in 2023, then gained by 8.73% to $12.1 million in 2024, then tumbled by 46.25% to $6.5 million in 2025, then soared by 60.06% to $10.4 million in 2026.
• The last three Current Assets figures came in at $10.4 million (Q1 2026), $6.5 million (Q4 2025), and $9.3 million (Q3 2025), per Business Quant data.